ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1983

Heated Mittens for Patients with Hand Osteoarthritis: A Randomized Trial

Cecilie Bartholdy1, Anna Døssing2, Zara Stisen1, Sabrina Mai Nielsen3, Henning Bliddal1, Robin Christensen4, Marius Henriksen1 and Karen Ellegaard1, 1The Parker Institute, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark, 2The Parker Institutte, Bispebjerg and Frederiksberg Hospital, Frederiksberg, Denmark, 3The Parker Institute, Bispebjerg and Frederiksberg Hospital, Copenhagen, Denmark, 4Musculoskeletal Statistics Unit, The Parker Institute, Copenhagen, Denmark

Meeting: ACR Convergence 2023

Keywords: hand, Osteoarthritis, Randomized Trial

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 14, 2023

Title: (1977–1995) Osteoarthritis – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Hand Osteoarthritis (OA) is common and causes pain and disability. Heat is anecdotally known to moderate symptoms and is conditionally recommended as a treatment for Hand OA by the American College of Rheumatology.

The purpose was to assess change in function after 6 weeks treatment with electrically heated mittens compared to sham mittens (electrical heating disabled) in participants with hand OA.

Methods: We performed a randomized superiority trial evaluating the potential benefit of heated mittens vs sham mittens during a 6-week trial period. We included participants diagnosed with hand OA according to the American College of Rheumatology classification criteria who had an AUSCAN (Australian/Canadian Osteoarthritis Hand Index) function of ≥ 40 on a 0-100 scale (higher scores indicate worse function). Participants were recruited from October 2020 to January 2023 and participated during the winter season (October to April 2020/21, 2021/22, 2022/23) in Denmark. Participants were randomly allocated (1:1) to heated mittens or sham mittens. The mittens appeared identically, including LED-lights that led when the heat function was activated. In the sham mittens, the heating was disabled. Participants were instructed to wear the mittens at least 15 minutes per day for 6 weeks. The primary outcome was change in AUSCAN function at week 6. Key secondary outcomes included AUSCAN pain, visual analog scale (VAS) global assessment of hand related problems, and grip strength. All analyses were based on the Intention-to-treat population, with continuous data modelled using repeated measures, mixed effects models adjusted for baseline variables.

Results: Two hundred participants were randomized to heated mittens (n = 100) or sham mittens (n = 100); 91 (Heat) and 95 (Sham) participants, completed the trial. The mean age was 71 years, 87 % were women, and median disease duration was 10 years (see Table 1). The mean (SE) change from baseline to week 6 in the AUSCAN function was -6.3 points (1.2) in the Heat group, and -3.3 points (1.2) in the Sham group, corresponding to a group difference of -3.0 points (95%CI, -6.3 to 0.4; P = 0.085; see Figure 1 and Table 2). Key secondary outcomes showed a statistically significant difference in AUSCAN pain of -5.9 points (95%CI, -9.5 to -2.2; P = 0.002), while no significant differences were found for VAS global assessment of hand related problems (0-100 VAS score) or grip strength.

Conclusion: Heated mittens were not superior to sham-heated mittens after 6 weeks regarding AUSCAN function but improvement in hand pain was observed.

Supporting image 1

Table 1. Baseline characteristics in the intention-to-treat population.

Supporting image 2

Table 2. Change from baseline in primary and key secondary outcomes at week 6 in the intention-to-treat population.

Supporting image 3

Figure 1. Trajectories for the primary efficacy outcome measure (AUSCAN function) from baseline to 6 weeks follow-up in the intention-to-treat population. Least-squares means for AUSCAN function (range 0_100) by group were estimated from a linear mixed model with group and week, and their interaction as fixed factors, and the baseline value as covariate; while patients were modelled as random effects. Errorbars indicate standard errors. AUSCAN, Australian/Canadian Osteoarthritis Hand Index.


Disclosures: C. Bartholdy: None; A. Døssing: None; Z. Stisen: None; S. Nielsen: None; H. Bliddal: None; R. Christensen: None; M. Henriksen: None; K. Ellegaard: None.

To cite this abstract in AMA style:

Bartholdy C, Døssing A, Stisen Z, Nielsen S, Bliddal H, Christensen R, Henriksen M, Ellegaard K. Heated Mittens for Patients with Hand Osteoarthritis: A Randomized Trial [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/heated-mittens-for-patients-with-hand-osteoarthritis-a-randomized-trial/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/heated-mittens-for-patients-with-hand-osteoarthritis-a-randomized-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology